Key points are not available for this paper at this time.
보조 화학요법 후 1년간의 트라스투주맙 치료는 HER2 양성 유방암 여성의 무병 생존율을 유의하게 향상시킵니다. (ClinicalTrials.gov 번호, NCT00045032.)
Building similarity graph...
Analyzing shared references across papers
Loading...
Martine Piccart
Marion Procter
Brian Leyland‐Jones
New England Journal of Medicine
Dana-Farber Cancer Institute
McGill University
Ludwig-Maximilians-Universität München
Building similarity graph...
Analyzing shared references across papers
Loading...
Piccart 등(목요일,)이 이 문제를 연구하였습니다.
www.synapsesocial.com/papers/69d7b52fb843b2be99490759 — DOI: https://doi.org/10.1056/nejmoa052306